Fundamental Concepts for New Clinical Trialists (PDF)

Name: Fundamental Concepts for New Clinical Trialists
Brand: Taylor & Francis
SKU: 127743792
Price: 61.49 EUR
Availability: OnlineOnly

(Sprache: Englisch)

Autoren: Scott Evans , Naitee Ting

Schreiben Sie einen Kommentar zu "Fundamental Concepts for New Clinical Trialists".

Fundamental Concepts for New Clinical Trialists, Scott Evans, Naitee Ting

Merken

Mehr zum Inhalt Autorenporträt Video

sofort als Download lieferbar

Bestellnummer: 127743792

eBook (pdf) 61.49 €

Download bestellen

Verschenken

30 DeutschlandCard Punkte sammeln

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Fundamental Concepts for New Clinical Trialists (PDF)“

This text describes the core scientific concepts of designing, data monitoring, analyzing, and reporting clinical trials as well as the practical aspects of trials not typically discussed in statistical methodology textbooks. It offers first-hand perspectives on real-world issues, such as common and challenging clinical trial designs and the proper reporting of clinical trial results in the medical literature. Drawing on their experiences in academia and industry, the authors provide a foundation for understanding the fundamental concepts necessary for working in clinical trials.

Autoren-Porträt von Scott Evans, Naitee Ting

Dr. Scott Evans teaches clinical trials at Harvard University, where he is the director of the Statistical and Data Management Center for the Antibacterial Resistance Leadership Group, an NIH-funded clinical trials network. He serves on a U.S. FDA Advisory Committee and several data monitoring committees for industry and NIH-sponsored clinical trials. He has been a recipient of the Mosteller Statistician of the Year Award and is a fellow of the American Statistical Association. Dr. Evans is a visiting professor at the Department of Medical Statistics at Osaka University and serves as the executive editor for CHANCE and the editor-in-chief of Statistical Communications in Infectious Diseases.

Dr. Naitee Ting has close to 30 years of experience in the pharmaceutical industry and currently works at Boehringer Ingelheim. He has also taught courses on clinical trials in the Department of Statistics at the University of Connecticut, University of Rhode Island, and Department of Biostatistics at Columbia University. He is a fellow of the American Statistical Association.